GO:0003184 pulmonary valve morphogenesis: Developmental Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003184 pulmonary valve morphogenesis is the biological process that generates and organizes the structure of the pulmonary valve, the three-leaflet valve separating the right ventricle from the pulmonary artery.
• Mechanosensitive transcription factors such as egr3 are required for cardiac valve morphogenesis, linking hemodynamic forces to valve leaflet formation.
• Disrupted pulmonary valve morphogenesis can produce pulmonary stenosis, a lesion detectable prenatally by echocardiography and postnatally by Doppler assessment [2,3].
• Fetal arrhythmias alter cardiac Doppler flow patterns and can affect ventricular function, illustrating how hemodynamics influence valve development [3,8].
• Severe pulmonary valve stenosis in premature infants is a clinically significant consequence of abnormal valve morphogenesis and requires specialized management.
• Research on pulmonary valve morphogenesis uses developmental models, echocardiography, and CRISPR-based gene editing to test causal roles of candidate genes [1,2,7].
Description
Pulmonary valve morphogenesis (GO:0003184) is the developmental process in which the structure of the pulmonary valve is generated and organized. The pulmonary valve guards the outflow tract of the right ventricle and consists of three semilunar leaflets that must form with precise geometry to permit unobstructed systolic ejection and prevent diastolic regurgitation. Because the valve is continuously exposed to hemodynamic forces, its morphogenesis integrates genetic programs with mechanotransduction. Understanding this process is essential for developmental biologists, cardiologists, and translational researchers because congenital pulmonary valve anomalies are a major source of right ventricular outflow tract obstruction [2,7]. During cardiogenesis, the pulmonary valve arises from the endocardial cushions of the conotruncal region, which undergo endocardial-to-mesenchymal transition, proliferation, and remodeling into thin mature leaflets. This remodeling depends on signaling between endocardium, myocardium, and neural crest-derived mesenchyme, and on the mechanical environment created by blood flow. Perturbations in these steps can lead to pulmonary stenosis or atresia, and prenatal echocardiography can detect such lesions before birth. For researchers, GO:0003184 provides a defined ontology node for annotating genes, regulatory networks, and experimental phenotypes related to pulmonary valve formation. Studies in model organisms and human cohorts have begun to identify mechanosensitive transcription factors and signaling pathways that control valve morphogenesis. This article summarizes the authoritative definition, the biological steps, the genes and regulatory mechanisms involved, disease links, and the experimental methods used to study pulmonary valve morphogenesis.
pulmonary valve morphogenesis At A Glance
| GO ID | GO:0003184 |
|---|---|
| GO term | pulmonary valve morphogenesis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Generation and organization of the pulmonary valve structure during development |
| Related anatomy | Pulmonary valve, right ventricular outflow tract, semilunar leaflets |
| Key cellular events | Endocardial cushion formation, endocardial-to-mesenchymal transition, leaflet remodeling |
| Representative regulator | egr3, a mechanosensitive transcription factor required for cardiac valve morphogenesis |
| Clinical relevance | Pulmonary stenosis and other congenital valve anomalies [2,7] |
What Is GO:0003184?
According to the Gene Ontology, pulmonary valve morphogenesis (GO:0003184) is the process in which the structure of the pulmonary valve is generated and organized. It encompasses the coordinated cellular and molecular events that shape the valve leaflets and supporting structures during embryonic and fetal development, ensuring a functional valve at birth.
Why Is pulmonary valve morphogenesis Important in Cell Biology?
Pulmonary valve morphogenesis is important because defects in this process cause congenital pulmonary valve disease, including pulmonary stenosis, which can lead to right ventricular pressure overload, hypertrophy, and heart failure if severe [2,7]. Because the valve forms under hemodynamic load, studying GO:0003184 also illuminates how mechanical forces are translated into transcriptional programs, a question relevant to both developmental biology and regenerative medicine. Moreover, prenatal detection of pulmonary valve abnormalities by echocardiography allows anticipatory management and counseling [2,3].
• Pulmonary valve morphogenesis ensures a competent valve that prevents backflow from the pulmonary artery into the right ventricle.
• Disrupted morphogenesis can cause pulmonary stenosis, a common congenital heart defect [2,7].
• Mechanosensitive transcription factors such as egr3 link blood flow forces to valve leaflet formation.
• Fetal arrhythmias can alter cardiac Doppler flow and ventricular function, indirectly affecting valve development [3,8].
• Prenatal echocardiography can identify pulmonary valve anomalies before birth, improving perinatal planning.
• Severe pulmonary valve stenosis in premature infants requires specialized neonatal care.
• Understanding valve morphogenesis informs tissue-engineering strategies for valve replacement.
• Animal models and CRISPR editing enable causal testing of candidate genes in valve development.
• GO:0003184 provides a standardized annotation for functional genomics and pathway analysis.
• Research on pulmonary valve morphogenesis overlaps with aortic valve disease mechanisms, including calcification and osteogenic signaling.
What Happens During pulmonary valve morphogenesis?
Endocardial cushion formation and EMT
In simple terms: Cells in the heart tube transform and migrate to build the primitive valve cushions.
Pulmonary valve morphogenesis begins with the formation of endocardial cushions in the conotruncal region. Endocardial cells undergo endocardial-to-mesenchymal transition (EndoMT), delaminate, and invade the underlying extracellular matrix. This process is regulated by signaling between the endocardium and myocardium, and by hemodynamic forces that influence cell behavior. The cushions serve as precursors for the future valve leaflets.
Hemodynamic mechanotransduction
In simple terms: Blood flow exerts mechanical forces that tell valve cells how to grow and shape the leaflets.
Blood flow across the developing outflow tract generates shear stress and pressure that are sensed by valve endocardium and mesenchyme. Mechanosensitive transcription factors, including egr3, are required for cardiac valve morphogenesis, indicating that mechanical cues are converted into transcriptional programs that control leaflet formation. Fetal Doppler studies show that flow patterns change with arrhythmias, which can affect ventricular function and potentially valve development [3,8].
Leaflet remodeling and stratification
In simple terms: The primitive cushions are sculpted into thin, layered leaflets with specialized cell and matrix organization.
After cushion formation, the valve primordia undergo remodeling into three distinct leaflets. This involves proliferation, apoptosis, and extracellular matrix reorganization. The process is tightly regulated to produce thin, flexible leaflets capable of withstanding lifelong mechanical stress. Disruption of remodeling can lead to thickened or fused leaflets, as seen in pulmonary stenosis [2,7].
Valve maturation and functional competence
In simple terms: The valve matures so it can open and close properly at birth.
Late morphogenesis involves maturation of the valve extracellular matrix and alignment of cells to form a competent barrier. This step ensures that the pulmonary valve can support the transition from fetal to neonatal circulation. Prenatal echocardiography can assess valve morphology and function, and abnormal findings may predict postnatal pulmonary stenosis.
Key Genes Involved in GO:0003184 pulmonary valve morphogenesis
The following genes and proteins have been implicated in pulmonary valve morphogenesis or related valve developmental processes based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| egr3 | Mechanosensitive transcription factor required for cardiac valve morphogenesis | Loss-of-function studies in model organisms reveal valve defects |
| TERT | Non-canonical activity initiates osteogenesis in calcific aortic valve disease | Relevant to valve calcification mechanisms that may overlap with developmental pathways |
| NR3C2 (MR) | Mineralocorticoid receptor in vascular smooth muscle, affecting blood pressure and vascular biology | Potential modifier of hemodynamic load on valve development |
| LYVE1 | Lymphatic marker involved in local lymphatic circulation and tissue inflammation | May influence valve interstitial environment and fibrosis |
| NOTCH1 | Not directly cited in provided references; broadly implicated in valve development | Candidate for CRISPR knockout studies in valve morphogenesis |
| GATA4 | Not directly cited in provided references; known cardiac transcription factor | Candidate for functional studies in pulmonary valve development |
| NKX2-5 | Not directly cited in provided references; early cardiac regulator | Potential upstream regulator of valve morphogenesis |
| TBX20 | Not directly cited in provided references; cardiac transcription factor | Candidate for knockout and rescue experiments |
| BMP2 | Not directly cited in provided references; signaling in cushion formation | Potential target for point mutation studies |
| TGFB1 | Not directly cited in provided references; EndoMT regulator | Relevant to epithelial-mesenchymal transition in valves |
| VEGFA | Not directly cited in provided references; angiogenesis and valve growth | Candidate for overexpression studies |
| HIF1A | Not directly cited in provided references; hypoxia response | May modulate valve cell metabolism |
| COL1A1 | Not directly cited in provided references; extracellular matrix component | Relevant to leaflet remodeling |
| ELN | Not directly cited in provided references; elastin in valve matrix | Candidate for matrix studies |
| ACTA2 | Not directly cited in provided references; smooth muscle actin | Marker of activated valve interstitial cells |
| MMP2 | Not directly cited in provided references; matrix remodeling enzyme | Potential mediator of leaflet sculpting |
| VIM | Not directly cited in provided references; mesenchymal marker | Used to assess EndoMT |
| PECAM1 | Not directly cited in provided references; endothelial marker | Used to identify endocardial cells |
How Is pulmonary valve morphogenesis Regulated?
Pulmonary valve morphogenesis is regulated by a combination of genetic and mechanical inputs. Mechanosensitive transcription factors such as egr3 are required for cardiac valve morphogenesis, indicating that hemodynamic forces are converted into transcriptional changes that control leaflet formation. Fetal arrhythmias can alter cardiac Doppler flow patterns and ventricular function, which may indirectly affect valve development [3,8]. Vascular and lymphatic factors, including mineralocorticoid receptor signaling and local lymphatic circulation, can influence the tissue environment and fibrosis that impact valve structure [5,6]. Additionally, non-canonical TERT activity has been linked to osteogenic processes in calcific aortic valve disease, suggesting that developmental and pathological valve programs may share regulatory nodes.
pulmonary valve morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| egr3 | Cardiac valve morphogenesis defects | Knockout zebrafish or mouse, mechanotransduction assays |
| TERT | Calcific aortic valve disease, osteogenesis | Overexpression in valve interstitial cells, calcification assays |
| NR3C2 | Vascular smooth muscle and blood pressure regulation | Conditional knockout in smooth muscle cells |
| LYVE1 | Lymphatic circulation disorder and fibrosis | Knockout mouse, lymphatic imaging |
| PECAM1 | Endocardial cell identity in valve development | Lineage tracing, knockout models |
Pulmonary stenosis
Pulmonary stenosis is a congenital heart defect characterized by narrowing of the pulmonary valve, often resulting from abnormal valve morphogenesis. Prenatal echocardiography can predict postnatal pulmonary stenosis by assessing valve morphology and flow. Severe pulmonary valve stenosis in premature infants is a critical condition requiring specialized management. Fetal Doppler studies have shown that arrhythmias can alter flow patterns, potentially contributing to valve abnormalities.
Calcific valve disease and osteogenic signaling
Although calcific aortic valve disease is primarily an adult degenerative condition, non-canonical TERT activity has been shown to initiate osteogenesis in calcific aortic valve disease, highlighting shared mechanisms with developmental valve biology. This suggests that pathways active during pulmonary valve morphogenesis may be reactivated in disease.
Vascular and lymphatic contributions to valve pathology
Mineralocorticoid receptor signaling in vascular smooth muscle affects blood pressure and vascular remodeling, which can influence hemodynamic load on the pulmonary valve. Local lymphatic circulation disorders promote tissue inflammation and organ fibrosis, which may affect valve interstitial cells and matrix composition.
From pulmonary valve morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is egr3 required for pulmonary valve morphogenesis? | egr3 knockout zebrafish or mouse |
| Does a point mutation in a candidate gene alter valve leaflet formation? | CRISPR point-mutation knock-in in zebrafish or mouse |
| Can overexpression of a signaling factor rescue valve defects? | Transgenic overexpression in valve endocardium |
| What is the role of mechanotransduction in valve development? | In vitro flow chamber with valve endothelial cells |
| How does lymphatic circulation affect valve fibrosis? | LYVE1 knockout mouse with valve histology |
| Does TERT activation induce osteogenic changes in valve cells? | TERT overexpression in valve interstitial cells |
How to Study the pulmonary valve morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Prenatal echocardiography | Valve morphology and flow | Prediction of postnatal pulmonary stenosis |
| Fetal Doppler | Cardiac flow patterns and ventricular function | Assessment during arrhythmias [3,8] |
| CRISPR knockout | Gene loss-of-function phenotypes | Testing egr3 requirement in valve morphogenesis |
| CRISPR point mutation | Specific amino acid changes | Modeling human variants in valve genes |
| Knock-in reporter | Gene expression localization | Lineage tracing of valve cell populations |
| Overexpression | Gain-of-function effects | Testing sufficiency of signaling factors |
| RNA-seq | Transcriptome changes | Identifying pathways in valve development |
| Histology and immunofluorescence | Tissue structure and protein localization | Assessing leaflet remodeling and matrix composition |
Prenatal and postnatal echocardiography
Echocardiography is a key method for assessing pulmonary valve morphology and function. Prenatal echocardiography can predict postnatal pulmonary stenosis by evaluating valve structure and flow. Fetal Doppler studies assess cardiac flow patterns during arrhythmias and ventricular function [3,8]. These non-invasive methods are essential for clinical diagnosis and for monitoring animal models of valve disease.
Genetic and developmental models
Model organisms such as zebrafish and mice are used to study pulmonary valve morphogenesis. Knockout of mechanosensitive transcription factor egr3 in zebrafish reveals valve morphogenesis defects. Lineage tracing and conditional knockouts allow researchers to dissect cell-type-specific contributions to valve formation.
Molecular and cellular assays
Endocardial-to-mesenchymal transition can be studied using markers such as VIM and PECAM1. Matrix remodeling is assessed by expression of MMPs and collagens. Mechanotransduction is investigated using flow chambers and shear stress experiments. These assays help link gene function to cellular behaviors in valve development.
CRISPR-based functional genomics
CRISPR knockout, point mutation, and knock-in models enable causal testing of candidate genes in pulmonary valve morphogenesis. For example, egr3 loss-of-function can be modeled by CRISPR knockout in zebrafish. Overexpression models can test sufficiency of signaling pathways. These approaches are complemented by bioinformatics analysis of valve transcriptomes.
How CRISPR Can Be Used to Study GO:0003184 pulmonary valve morphogenesis
Knockout
CRISPR knockout is used to ablate candidate genes and assess their requirement for pulmonary valve morphogenesis. For example, knockout of egr3 in zebrafish results in cardiac valve morphogenesis defects, demonstrating its essential role. Knockout models can be analyzed by echocardiography and histology to quantify valve abnormalities.
Point Mutation
CRISPR point mutation introduces specific nucleotide changes to model human variants or to dissect functional domains. This approach can test whether a single amino acid substitution in a transcription factor like egr3 affects its mechanosensitive activity during valve development. Point-mutation models are valuable for genotype-phenotype correlation.
Knock-in
Knock-in strategies insert reporters, tags, or human sequences into endogenous loci. A tagged knock-in of egr3 can reveal its expression pattern and protein interactions in the developing pulmonary valve. Knock-in of disease-associated variants can model congenital valve defects.
Overexpression
CRISPR activation or transgenic overexpression can test whether increased dosage of a gene is sufficient to drive or rescue valve morphogenesis. Overexpression of TERT in valve interstitial cells induces osteogenic changes relevant to calcific valve disease. Such models help identify therapeutic targets.
How EDITGENE Supports pulmonary valve morphogenesis Research
Researchers studying pulmonary valve morphogenesis-related genes often need to determine whether a candidate gene is causally involved in valve development or disease. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional studies of genes implicated in GO:0003184.
Contact EDITGENE today to design your custom CRISPR model for pulmonary valve morphogenesis research.
Frequently Asked Questions About pulmonary valve morphogenesis
What is pulmonary valve morphogenesis?
Pulmonary valve morphogenesis (GO:0003184) is the biological process in which the structure of the pulmonary valve is generated and organized during development.
What genes are involved in pulmonary valve morphogenesis?
egr3 is a mechanosensitive transcription factor required for cardiac valve morphogenesis. Other genes such as TERT, NR3C2, and LYVE1 have been implicated in related valve and vascular processes [4,5,6].
How is pulmonary valve morphogenesis studied?
It is studied using model organisms, echocardiography, Doppler flow assessment, and CRISPR-based gene editing [1,2,3].
What diseases are linked to abnormal pulmonary valve morphogenesis?
Abnormal pulmonary valve morphogenesis can lead to pulmonary stenosis, which may be detected prenatally and can be severe in premature infants [2,7].
What is the role of mechanotransduction in pulmonary valve morphogenesis?
Mechanical forces from blood flow are sensed by valve cells and converted into transcriptional programs; egr3 is a mechanosensitive transcription factor required for valve morphogenesis.
Can prenatal echocardiography predict pulmonary stenosis?
Yes, prenatal echocardiography can predict postnatal pulmonary stenosis by assessing valve morphology and flow.
How do fetal arrhythmias affect valve development?
Fetal arrhythmias alter cardiac Doppler flow patterns and ventricular function, which may indirectly influence valve development [3,8].
What is the connection between pulmonary valve morphogenesis and calcific valve disease?
Non-canonical TERT activity initiates osteogenesis in calcific aortic valve disease, suggesting shared mechanisms with developmental valve biology.
What CRISPR models are available for studying pulmonary valve morphogenesis?
Knockout, point mutation, knock-in, and overexpression models can be generated to test gene function in valve development.
Why is GO:0003184 important for researchers?
GO:0003184 provides a standardized ontology term for annotating genes and pathways involved in pulmonary valve formation, facilitating functional genomics and disease research [1,2].
Conclusion
Pulmonary valve morphogenesis (GO:0003184) is a tightly regulated developmental process that integrates genetic programs with hemodynamic forces to build a functional pulmonary valve. Mechanosensitive transcription factors such as egr3 are essential for valve morphogenesis, and disruptions in this process can cause pulmonary stenosis and other congenital valve anomalies [2,7]. Understanding the cellular and molecular steps of valve development is critical for diagnosing and treating valve disease. CRISPR-based models and advanced imaging provide powerful tools to dissect these mechanisms and to identify new therapeutic targets.
References
- 1. da Silva AR et al.. 2024. egr3 is a mechanosensitive transcription factor gene required for cardiac valve morphogenesis.. Sci Adv 10(20):eadl0633 PMID: 38748804
- 2. Wang L et al.. 2026. The Predictive Role of Prenatal Echocardiography in the Diagnosis of Postnatal Pulmonary Stenosis.. Pediatr Cardiol 47(4):1750-1757 PMID: 40736580
- 3. Reed KL et al.. 1987. Cardiac Doppler flows during fetal arrhythmias: physiologic consequences.. Obstet Gynecol 70(1):1-6 PMID: 2439963
- 4. Cuevas RA et al.. 2025. Non-Canonical TERT Activity Initiates Osteogenesis in Calcific Aortic Valve Disease.. Circ Res 136(4):403-421 PMID: 39835393
- 5. Camarda ND et al.. 2024. Mineralocorticoid Receptors in Vascular Smooth Muscle: Blood Pressure and Beyond.. Hypertension 81(5):1008-1020 PMID: 38426347
- 6. Wu X et al.. 2026. Local lymphatic circulation disorder: A key promoter of tissue inflammation and organ fibrosis.. Life Sci 402:124575 PMID: 42409261
- 7. Rigby ML. 2012. Severe aortic or pulmonary valve stenosis in premature infants.. Early Hum Dev 88(5):291-4 PMID: 22464565
- 8. DeVore GR. 2005. Assessing fetal cardiac ventricular function.. Semin Fetal Neonatal Med 10(6):515-41 PMID: 16257825
